Biogen tweaks confirmatory trial of Alzheimer’s drug AduhelmBiogen and Eisai have increased the earning potential of their Alzheimer’s drug Aduhelm by expanding the post-marketing trial Share XBiogen tweaks confirmatory trial of Alzheimer’s drug Aduhelmhttps://pharmaphorum.com/news/biogen-tweaks-confirmatory-trial-of-alzheimers-drug-aduhelm/
Paul Stoffels swiftly resurfaces as Galapagos’ next CEOPaul Stoffels’ retirement at the end of last year after nine years as head of R&D at Johnson Share XPaul Stoffels swiftly resurfaces as Galapagos’ next CEOhttps://pharmaphorum.com/news/paul-stoffels-swiftly-resurfaces-as-galapagos-next-ceo/
GSK, Verily-backed Galvani starts trials of bioelectronic arthritis therapyThe first patient has been treated with an implantable bioelectronic device developed by Galvani Therapeutics, set up by Share XGSK, Verily-backed Galvani starts trials of bioelectronic arthritis therapyhttps://pharmaphorum.com/news/gsk-verily-backed-galvani-starts-trials-of-bioelectronic-arthritis-therapy/
Moderna starts dosing patients with its Omicron COVID jabModerna has started human trials of an Omicron version of its COVID-19 vaccine SpikeVax, just in case a Share XModerna starts dosing patients with its Omicron COVID jabhttps://pharmaphorum.com/news/moderna-starts-dosing-patients-with-its-omicron-covid-jab/
Health gaming firm Akili takes blank cheque route to public listingAkili Interactive has agreed a merger with special purpose acquisition company (SPAC) Social Capital Suvretta Holdings Corp I Share XHealth gaming firm Akili takes blank cheque route to public listinghttps://pharmaphorum.com/news/health-gaming-firm-akili-takes-blank-cheque-route-to-public-listing/
Immunocore claims first-ever FDA approval for TCR cancer therapyImmunocore has secured a piece of biotech industry history, becoming the first company to get an FDA approval Share XImmunocore claims first-ever FDA approval for TCR cancer therapyhttps://pharmaphorum.com/news/immunocore-claims-first-ever-fda-approval-for-tcr-cancer-therapy/
Digital health firms nab record $57.2bn funding in 2021; reportThe final numbers are in, and now it’s official – digital health companies raked in a massive $57.2 Share XDigital health firms nab record $57.2bn funding in 2021; reporthttps://pharmaphorum.com/news/digital-health-firms-nab-record-57-2bn-funding-in-2021-report/
FDA slaps hold on trials of Gilead’s CD47 drug magrolimabThe FDA has placed a partial clinical fold on clinical trials of Gilead Sciences’ magrolimab, the centre piece Share XFDA slaps hold on trials of Gilead’s CD47 drug magrolimabhttps://pharmaphorum.com/news/fda-slaps-hold-on-trials-of-gileads-cd47-drug-magrolimab/
J&J eyes “tuck-in deals” as consumer health spinoff nearsJohnson & Johnson has said the impending spin-off of its consumer health division won’t stop it from “forging Share XJ&J eyes “tuck-in deals” as consumer health spinoff nearshttps://pharmaphorum.com/news/jj-eyes-tuck-in-deals-as-consumer-health-spinoff-nears/
